Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma

Acta Physiologica Hungarica

Volumn 95, Issue 2, 2008, Pages 209-218

  Selmeci, László ^a   Seres, L ^b   Soos P ^a   Szekely M ^a   Acsady Gy ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Institute of Cardiology Budapest   (Hungary)

Author keywords

Advanced oxidation protein products (AOPP); Critically ill patients; Kinetic assay; Oxidative stress; Patient monitoring

Indexed keywords

BIOLOGICAL MARKER; CHLORAMINE DERIVATIVE; CHLORAMINE-T; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; PLASMA PROTEIN; TOLUENESULFONIC ACID DERIVATIVE; TOSYLCHLORAMIDE SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOASSAY; BLOOD; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; KINETICS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; CARDIOVASCULAR DISEASES; CHLORAMINES; FEMALE; HUMANS; INDICATORS AND REAGENTS; KINETICS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOSYL COMPOUNDS;

EID: 44649136765     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.95.2008.2.5     Document Type: Article

References (15)

1. Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A: Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis. Am. J. Med. 116, 595-600 (2004)
2. Bhattacharyya DK, Adak S, Bandyopadhyay U, Banerjee RK: Mechanism of inhibition of horseradish peroxidase-catatalysed iodide oxidation by EDTA. Biochem. J. 298, 281-288 (1994)
3. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R: Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr. Res. 47, 221-224 (2000)
4. Buonocore G, Perrone S, Longini M, Vezzosi P, Marzocchi B, Paffetti P, Bracci R: Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr. Res. 52, 46-49 (2002)
5. Capeillère-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V: Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim. Biophys. Acta 1689, 91-102 (2004)
6. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin. Chem. 52, 601-623 (2006)
7. Kalousova M, Skrha J, Zima T: Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res. 51, 597-604 (2002)
8. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M: Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162, 221-225 (2002)
9. Lemineur T, Deby-Dupont G, Preiser JC: Biomarkers of oxidative stress in critically ill patients: what should be measured, when and how? Curr. Opin. Clin. Nutr. Metab. Care. 9, 704-710 (2006)
10. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C: Biomarkers of diabetes - associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic. Biol. Med. 34, 1563-1574 (2003)
11. Sebekova K, Gazdikova K, Syrova D, Blazicek P, Schinzel R, Heidland A, Spustova V, Dzurik R: Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidative stress and potential modulation of advanced glycation end products. J. Hum. Hypertens. 17, 265-270 (2003)
12. Selmeci L, Seres L, Antal M, Lukács J, Regöly-Mérei A, Acsády G: Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique. Clin. Chem. Lab. Med. 43, 294-297 (2005)
13. Selmeci L, Székely M, Soós P, Seres L, Klinga N, Geiger A, Acsády G: Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Rad. Res. 40, 952-958 (2006)
14. Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B: Overestimation of advanced oxidation protein products in uremic plasma due to the presence of triglycerides and other endogenous factors. Clin. Chim. Acta 379, 87-94 (2007)
15. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49, 1304-1313 (1996)